Joel Greenblatt Jazz Pharmaceuticals PLC Transaction History

Gotham Asset Management, LLC

$21.9 Billion
Q3 2025

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Gotham Asset Management, LLC holds 51,192 shares of JAZZ stock, worth $7.22 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

51,192

Previous 68,472 25.24%

Holding current value

$7.22 Million

Previous $7.27 Million 7.14%

% of portfolio

0.03%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$105.93 - $131.8 $1.83 Million - $2.28 Million	-17,280 Reduced 25.24%	51,192 $6.75 Million
Q2 2025 Aug 14, 2025	BUY	$97.78 - $126.44 $1.77 Million - $2.29 Million	18,077 Added 35.87%	68,472 $7.27 Million
Q1 2025 May 15, 2025	BUY	$120.07 - $144.17 $4.24 Million - $5.09 Million	35,304 Added 233.94%	50,395 $6.26 Million
Q4 2024 Feb 14, 2025	SELL	$107.32 - $127.74 $637,695 - $759,031	-5,942 Reduced 28.25%	15,091 $1.86 Million
Q3 2024 Nov 14, 2024	BUY	$100.57 - $116.37 $1.51 Million - $1.75 Million	15,033 Added 250.55%	21,033 $2.34 Million

Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $326,371 - $373,597	3,140 Added 109.79%	6,000 $640,000
Q1 2024 May 15, 2024	SELL	$115.19 - $132.77 $110,927 - $127,857	-963 Reduced 25.19%	2,860 $344,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $2.3 Million - $2.74 Million	-20,149 Reduced 84.05%	3,823 $470,000
Q3 2023 Nov 14, 2023	SELL	$122.0 - $145.31 $636,840 - $758,518	-5,220 Reduced 17.88%	23,972 $3.1 Million
Q2 2023 Aug 14, 2023	BUY	$122.5 - $147.16 $215,110 - $258,412	1,756 Added 6.4%	29,192 $3.62 Million
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $467,858 - $560,361	3,492 Added 14.58%	27,436 $4.01 Million
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $1.56 Million - $1.92 Million	11,998 Added 100.44%	23,944 $3.81 Million
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $1.51 Million - $1.93 Million	11,946 New	11,946 $1.59 Million
Q3 2021 Nov 15, 2021	SELL	$128.64 - $184.79 $207,624 - $298,251	-1,614 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$160.2 - $186.42 $1.66 Million - $1.93 Million	-10,350 Reduced 86.51%	1,614 $287,000
Q1 2021 May 17, 2021	BUY	$150.19 - $173.5 $1.53 Million - $1.76 Million	10,163 Added 564.3%	11,964 $1.97 Million
Q4 2020 Feb 16, 2021	SELL	$140.71 - $165.05 $33,911 - $39,777	-241 Reduced 11.8%	1,801 $297,000
Q3 2020 Nov 16, 2020	SELL	$105.46 - $144.13 $2.06 Million - $2.81 Million	-19,521 Reduced 90.53%	2,042 $291,000
Q2 2020 Aug 13, 2020	BUY	$95.68 - $121.88 $2.06 Million - $2.63 Million	21,563 New	21,563 $2.38 Million
Q1 2020 May 15, 2020	SELL	$87.74 - $152.74 $378,598 - $659,073	-4,315 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$117.65 - $153.73 $993,554 - $1.3 Million	-8,445 Reduced 66.18%	4,315 $644,000
Q3 2019 Nov 14, 2019	SELL	$125.18 - $143.24 $1.36 Million - $1.56 Million	-10,864 Reduced 45.99%	12,760 $1.64 Million
Q2 2019 Aug 14, 2019	BUY	$125.55 - $144.48 $266,919 - $307,164	2,126 Added 9.89%	23,624 $3.37 Million
Q1 2019 May 15, 2019	SELL	$121.81 - $142.95 $2.2 Million - $2.58 Million	-18,055 Reduced 45.65%	21,498 $3.07 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $205,329 - $295,296	-1,771 Reduced 4.29%	39,553 $4.9 Million
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $6.65 Million - $7.46 Million	41,324 New	41,324 $6.95 Million
Q1 2018 May 15, 2018	SELL	$135.59 - $157.16 $2.33 Million - $2.7 Million	-17,170 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $2.21 Million - $2.54 Million	-16,887 Reduced 49.58%	17,170 $2.31 Million
Q3 2017 Nov 14, 2017	BUY	$142.62 - $155.6 $4.86 Million - $5.3 Million	34,057	34,057 $4.98 Million

Others Institutions Holding JAZZ

# of Institutions

569

Shares Held

61.8M

Call Options Held

856K

Put Options Held

178K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.84B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account